Cargando…
Altered liver expression of genes involved in lipid and glucose metabolism in mice with partial IGF-1 deficiency: an experimental approach to metabolic syndrome
BACKGROUND: Insulin growth factor 1 (IGF-1) has multiple effects on metabolism. Much evidence suggests that the deficiency of this hormone increases insulin resistance, impairs lipid metabolism, augments oxidative damage and deregulates the neuro-hormonal axis. An inverse relationship between IGF-1...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604722/ https://www.ncbi.nlm.nih.gov/pubmed/26467524 http://dx.doi.org/10.1186/s12967-015-0684-9 |
_version_ | 1782395094283845632 |
---|---|
author | De Ita, J. Rodríguez Castilla-Cortázar, I. Aguirre, G. A. Sánchez-Yago, C. Santos-Ruiz, M. Olleros Guerra-Menéndez, L. Martín-Estal, I. García-Magariño, M. Lara-Díaz, V. J. Puche, J. E. Muñoz, U. |
author_facet | De Ita, J. Rodríguez Castilla-Cortázar, I. Aguirre, G. A. Sánchez-Yago, C. Santos-Ruiz, M. Olleros Guerra-Menéndez, L. Martín-Estal, I. García-Magariño, M. Lara-Díaz, V. J. Puche, J. E. Muñoz, U. |
author_sort | De Ita, J. Rodríguez |
collection | PubMed |
description | BACKGROUND: Insulin growth factor 1 (IGF-1) has multiple effects on metabolism. Much evidence suggests that the deficiency of this hormone increases insulin resistance, impairs lipid metabolism, augments oxidative damage and deregulates the neuro-hormonal axis. An inverse relationship between IGF-1 levels and the prevalence of Metabolic Syndrome (MetS) with its cardiovascular complications has been identified. However, the underlying mechanisms linking IGF-1 and MetS are still poorly understood. In order to elucidate such mechanisms, the aim of this work was to study, in mice with partial IGF-1 deficiency, liver expression of genes involved in glucose and lipid metabolism as well as serum levels of glucose, triglycerides and cholesterol, as well as liver malondialdehyde (MDA) levels, as a marker for oxidative damage. METHODS: Three experimental groups were studied in parallel: Controls (CO), wild type mice (igf-1(+/+)); untreated heterozygous mice (Hz, igf-1(+/−)) and Hz (igf-1(+/−)) mice treated with low doses of IGF-1 for 10 days (Hz + IGF-1). RESULTS: A reduction of IGF-1 serum levels in the Hz group was found, which was normalized by IGF-1 therapy. Serum levels of glucose, triglycerides and cholesterol were significantly increased in the untreated Hz group as compared to both controls and Hz + IGF-1 groups. The expression of genes involved in gluconeogenesis, glycogenolysis, lipid synthesis and transport, and catabolism were altered in untreated Hz animals and the expression of most of them was normalized by IGF-1 therapy; MDA was also significantly increased in the Hz untreated group. CONCLUSIONS: The mere partial IGF-1 deficiency is responsible for the reduction in the expression of genes involved in glucose and lipid metabolism, resulting in dyslipidemia and hyperglycemia. Such genetic alterations may seriously contribute to the establishment of MetS. |
format | Online Article Text |
id | pubmed-4604722 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-46047222015-10-15 Altered liver expression of genes involved in lipid and glucose metabolism in mice with partial IGF-1 deficiency: an experimental approach to metabolic syndrome De Ita, J. Rodríguez Castilla-Cortázar, I. Aguirre, G. A. Sánchez-Yago, C. Santos-Ruiz, M. Olleros Guerra-Menéndez, L. Martín-Estal, I. García-Magariño, M. Lara-Díaz, V. J. Puche, J. E. Muñoz, U. J Transl Med Research BACKGROUND: Insulin growth factor 1 (IGF-1) has multiple effects on metabolism. Much evidence suggests that the deficiency of this hormone increases insulin resistance, impairs lipid metabolism, augments oxidative damage and deregulates the neuro-hormonal axis. An inverse relationship between IGF-1 levels and the prevalence of Metabolic Syndrome (MetS) with its cardiovascular complications has been identified. However, the underlying mechanisms linking IGF-1 and MetS are still poorly understood. In order to elucidate such mechanisms, the aim of this work was to study, in mice with partial IGF-1 deficiency, liver expression of genes involved in glucose and lipid metabolism as well as serum levels of glucose, triglycerides and cholesterol, as well as liver malondialdehyde (MDA) levels, as a marker for oxidative damage. METHODS: Three experimental groups were studied in parallel: Controls (CO), wild type mice (igf-1(+/+)); untreated heterozygous mice (Hz, igf-1(+/−)) and Hz (igf-1(+/−)) mice treated with low doses of IGF-1 for 10 days (Hz + IGF-1). RESULTS: A reduction of IGF-1 serum levels in the Hz group was found, which was normalized by IGF-1 therapy. Serum levels of glucose, triglycerides and cholesterol were significantly increased in the untreated Hz group as compared to both controls and Hz + IGF-1 groups. The expression of genes involved in gluconeogenesis, glycogenolysis, lipid synthesis and transport, and catabolism were altered in untreated Hz animals and the expression of most of them was normalized by IGF-1 therapy; MDA was also significantly increased in the Hz untreated group. CONCLUSIONS: The mere partial IGF-1 deficiency is responsible for the reduction in the expression of genes involved in glucose and lipid metabolism, resulting in dyslipidemia and hyperglycemia. Such genetic alterations may seriously contribute to the establishment of MetS. BioMed Central 2015-10-14 /pmc/articles/PMC4604722/ /pubmed/26467524 http://dx.doi.org/10.1186/s12967-015-0684-9 Text en © Rodríguez De Ita et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research De Ita, J. Rodríguez Castilla-Cortázar, I. Aguirre, G. A. Sánchez-Yago, C. Santos-Ruiz, M. Olleros Guerra-Menéndez, L. Martín-Estal, I. García-Magariño, M. Lara-Díaz, V. J. Puche, J. E. Muñoz, U. Altered liver expression of genes involved in lipid and glucose metabolism in mice with partial IGF-1 deficiency: an experimental approach to metabolic syndrome |
title | Altered liver expression of genes involved in lipid and glucose metabolism in mice with partial IGF-1 deficiency: an experimental approach to metabolic syndrome |
title_full | Altered liver expression of genes involved in lipid and glucose metabolism in mice with partial IGF-1 deficiency: an experimental approach to metabolic syndrome |
title_fullStr | Altered liver expression of genes involved in lipid and glucose metabolism in mice with partial IGF-1 deficiency: an experimental approach to metabolic syndrome |
title_full_unstemmed | Altered liver expression of genes involved in lipid and glucose metabolism in mice with partial IGF-1 deficiency: an experimental approach to metabolic syndrome |
title_short | Altered liver expression of genes involved in lipid and glucose metabolism in mice with partial IGF-1 deficiency: an experimental approach to metabolic syndrome |
title_sort | altered liver expression of genes involved in lipid and glucose metabolism in mice with partial igf-1 deficiency: an experimental approach to metabolic syndrome |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604722/ https://www.ncbi.nlm.nih.gov/pubmed/26467524 http://dx.doi.org/10.1186/s12967-015-0684-9 |
work_keys_str_mv | AT deitajrodriguez alteredliverexpressionofgenesinvolvedinlipidandglucosemetabolisminmicewithpartialigf1deficiencyanexperimentalapproachtometabolicsyndrome AT castillacortazari alteredliverexpressionofgenesinvolvedinlipidandglucosemetabolisminmicewithpartialigf1deficiencyanexperimentalapproachtometabolicsyndrome AT aguirrega alteredliverexpressionofgenesinvolvedinlipidandglucosemetabolisminmicewithpartialigf1deficiencyanexperimentalapproachtometabolicsyndrome AT sanchezyagoc alteredliverexpressionofgenesinvolvedinlipidandglucosemetabolisminmicewithpartialigf1deficiencyanexperimentalapproachtometabolicsyndrome AT santosruizmolleros alteredliverexpressionofgenesinvolvedinlipidandglucosemetabolisminmicewithpartialigf1deficiencyanexperimentalapproachtometabolicsyndrome AT guerramenendezl alteredliverexpressionofgenesinvolvedinlipidandglucosemetabolisminmicewithpartialigf1deficiencyanexperimentalapproachtometabolicsyndrome AT martinestali alteredliverexpressionofgenesinvolvedinlipidandglucosemetabolisminmicewithpartialigf1deficiencyanexperimentalapproachtometabolicsyndrome AT garciamagarinom alteredliverexpressionofgenesinvolvedinlipidandglucosemetabolisminmicewithpartialigf1deficiencyanexperimentalapproachtometabolicsyndrome AT laradiazvj alteredliverexpressionofgenesinvolvedinlipidandglucosemetabolisminmicewithpartialigf1deficiencyanexperimentalapproachtometabolicsyndrome AT pucheje alteredliverexpressionofgenesinvolvedinlipidandglucosemetabolisminmicewithpartialigf1deficiencyanexperimentalapproachtometabolicsyndrome AT munozu alteredliverexpressionofgenesinvolvedinlipidandglucosemetabolisminmicewithpartialigf1deficiencyanexperimentalapproachtometabolicsyndrome |